Cytopénies auto-immunes au décours de maladies de Hogkin en rémission
Thibault Comont(Institut universitaire du cancer de Toulouse Oncopole), O. Beyne-Rauzy(Hôpital Purpan), Guillaume Martin‐Blondel(Centre Hospitalier Universitaire de Toulouse), T. Challan-Belval(Hôpital Purpan), D. Adoué, S. Ollier(Institut universitaire du cancer de Toulouse Oncopole)
Cited by 1
Related Papers
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
|The Lancet Infectious Diseases|2017|587
Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study
|Radiology|2020|472
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies
|Journal of Allergy and Clinical Immunology|2017|316
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
|Journal of Thrombosis and Haemostasis|2018|138